Jessica Zucman-Rossi Selected Research

Hypoxia (Hypoxemia)

6/2021	MicroRNAs Targeting HIF-2α, VEGFR1 and/or VEGFR2 as Potential Predictive Biomarkers for VEGFR Tyrosine Kinase and HIF-2α Inhibitors in Metastatic Clear-Cell Renal Cell Carcinoma.
4/2018	Pro-angiogenic gene expression is associated with better outcome on sunitinib in metastatic clear-cell renal cell carcinoma.
3/2015	Molecular subtypes of clear cell renal cell carcinoma are associated with sunitinib response in the metastatic setting.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jessica Zucman-Rossi Research Topics

Disease

120	Neoplasms (Cancer) 02/2024 - 11/2003
65	Hepatocellular Carcinoma (Hepatoma) 02/2024 - 05/2003
32	Liver Cell Adenoma (Hepatocellular Adenoma) 01/2023 - 11/2003
25	Carcinogenesis 02/2024 - 03/2005
21	Liver Neoplasms (Liver Cancer) 02/2024 - 12/2011
20	Renal Cell Carcinoma (Grawitz Tumor) 01/2022 - 03/2005
12	Adenoma (Adenomas) 04/2017 - 05/2003
10	Inflammation (Inflammations) 04/2021 - 05/2007
7	Liver Diseases (Liver Disease) 01/2023 - 01/2016
7	Fibrosis (Cirrhosis) 01/2023 - 03/2009
6	Malignant Mesothelioma 01/2020 - 12/2005
5	Hepatoblastoma 02/2024 - 01/2019
5	Hemorrhage 11/2022 - 08/2009
5	Neoplasm Metastasis (Metastasis) 06/2022 - 04/2012
5	Colorectal Neoplasms (Colorectal Cancer) 01/2017 - 05/2003
5	Focal Nodular Hyperplasia 12/2010 - 05/2007
4	Cholangiocarcinoma 12/2023 - 01/2022
3	Hypoxia (Hypoxemia) 06/2021 - 03/2015
3	Carcinoma (Carcinomatosis) 04/2014 - 03/2006
3	Mesothelioma 05/2013 - 12/2005
2	Kidney Neoplasms (Kidney Cancer) 01/2023 - 10/2018
2	Liver Failure 01/2022 - 06/2013
2	Infections 04/2021 - 06/2008
2	Polyploidy 01/2021 - 01/2020
2	Hypersensitivity (Allergy) 01/2019 - 02/2010
2	Non-alcoholic Fatty Liver Disease 01/2019 - 01/2016
2	Alcoholic Liver Diseases (Alcoholic Liver Disease) 01/2019 - 01/2019
2	Genomic Instability 04/2016 - 01/2012
2	Hepatitis B 01/2016 - 10/2015
2	Lung Neoplasms (Lung Cancer) 05/2013 - 01/2010
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 05/2013 - 01/2010

Drug/Important Bio-Agent (IBA)

31	CateninsIBA 02/2024 - 11/2010
23	beta CateninIBA 04/2022 - 08/2004
17	Biomarkers (Surrogate Marker)IBA 06/2022 - 10/2011
12	DNA (Deoxyribonucleic Acid)IBA 02/2024 - 11/2005
12	Proteins (Proteins, Gene)FDA Link 10/2022 - 01/2009
12	Messenger RNA (mRNA)IBA 08/2020 - 03/2005
10	RNA (Ribonucleic Acid)IBA 12/2023 - 01/2011
10	Telomerase (Telomerase Reverse Transcriptase)IBA 05/2022 - 03/2005
10	Transcription Factors (Transcription Factor)IBA 01/2022 - 08/2002
10	Sunitinib (Sutent)FDA Link 01/2022 - 01/2014
10	MicroRNAs (MicroRNA)IBA 06/2021 - 06/2008
10	Hepatocyte Nuclear Factor 1-alpha (Hepatocyte Nuclear Factor 1 alpha)IBA 02/2010 - 05/2003
7	Tyrosine Kinase InhibitorsIBA 01/2023 - 12/2013
7	Interleukin-6 (Interleukin 6)IBA 01/2020 - 01/2009
7	Oral ContraceptivesIBA 04/2014 - 09/2004
5	LipidsIBA 10/2023 - 05/2007
5	Phosphotransferases (Kinase)IBA 01/2023 - 02/2016
5	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2023 - 04/2018
5	LigandsIBA 01/2021 - 12/2007
5	Hepatocyte Nuclear FactorsIBA 05/2017 - 03/2004
4	Bevacizumab (Avastin)FDA Link 12/2023 - 04/2012
4	CyclinsIBA 01/2022 - 10/2015
4	Small Interfering RNA (siRNA)IBA 12/2018 - 10/2007
4	Glutamate-Ammonia Ligase (Glutamine Synthetase)IBA 04/2017 - 03/2009
4	AsbestosIBA 05/2013 - 12/2005
3	Cisplatin (Platino)FDA LinkGeneric 02/2024 - 01/2019
3	Histone MethyltransferasesIBA 10/2023 - 02/2016
3	NivolumabIBA 01/2022 - 10/2019
3	ParaffinIBA 12/2021 - 04/2017
3	Formaldehyde (Formol)FDA Link 12/2021 - 11/2005
3	CarcinogensIBA 01/2021 - 12/2005
3	Hormones (Hormone)IBA 08/2020 - 09/2004
3	MethyltransferasesIBA 01/2019 - 10/2015
3	Cyclin A2IBA 12/2018 - 10/2015
3	Aflatoxin B1 (Aflatoxin B)IBA 11/2017 - 05/2015
3	C-Reactive ProteinIBA 04/2017 - 07/2014
2	atezolizumabIBA 12/2023 - 10/2019
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2023 - 11/2017
2	Reticulin (Reticular Fiber)IBA 01/2023 - 12/2017
2	Estrogens (Estrogen)FDA Link 01/2023 - 08/2020
2	Apolipoproteins B (ApoB)IBA 10/2022 - 01/2020
2	CytokinesIBA 10/2022 - 04/2015
2	IpilimumabIBA 01/2022 - 10/2019
2	Cadherins (E-Cadherin)IBA 01/2022 - 01/2007
2	Long Noncoding RNAIBA 10/2021 - 01/2021
2	Sorafenib (BAY 43-9006)FDA Link 01/2019 - 05/2011
2	Glutamine (L-Glutamine)FDA Link 01/2019 - 12/2016
2	pazopanib FDA Link 01/2019 - 01/2018
2	alpha-Fetoproteins (alpha-Fetoprotein)IBA 01/2018 - 10/2017
2	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 11/2017 - 11/2016
2	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 12/2016 - 06/2008
2	Mitogen-Activated Protein KinasesIBA 11/2016 - 05/2012
2	TOR Serine-Threonine KinasesIBA 11/2016 - 04/2015
2	Lysine (L-Lysine)FDA Link 03/2016 - 10/2015
2	Serum Amyloid A Protein (Serum Amyloid A)IBA 01/2016 - 03/2009
2	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 11/2013 - 01/2009
2	SmokeIBA 05/2013 - 01/2010
2	Fatty Acids (Saturated Fatty Acids)IBA 02/2013 - 05/2007
2	Adenosine Triphosphatases (ATPase)IBA 12/2009 - 10/2007
2	Hepatocyte Nuclear Factor 1IBA 05/2007 - 05/2003

Therapy/Procedure

25	Therapeutics 12/2023 - 01/2007
6	Contraception (Birth Control) 01/2023 - 12/2006
5	Drug Therapy (Chemotherapy) 10/2021 - 04/2012
5	Precision Medicine 01/2020 - 12/2015
2	Neoadjuvant Therapy 02/2024 - 01/2019
2	Genomic Medicine 12/2023 - 01/2019
2	Metastasectomy 06/2022 - 10/2018
2	Immunotherapy 01/2022 - 01/2021
2	Biological Therapy 11/2014 - 05/2011